CRP and metabolic syndrome: Notably, Song et al. identified CysC as the strongest predictor of both all-cause and cardiovascular mortality in patients with MetS, demonstrating superior prognostic performance compared to eGFR, blood urea nitrogen, creatinine, uric acid, and CRP [17].